Clinical

Dataset Information

0

Nivolumab and Ipilimumab in Patients With dMMR and/or MSI Metastatic Colorectal Cancer Resistant to Anti-PD1 Monotherapy


ABSTRACT: NIPIRESCUE is a national, single-arm, open-label phase II study. The study aims to evaluate the clinical activity of nivolumab and ipilimumab in patients with MSI/dMMR mCRC resistant to anti-PD1 monotherapy and previously treated with fluoropyrimidine, oxaliplatine, irinotecan, and anti- vascular endothelial growth factor (VEGF) or anti- epidermal growth factor receptor (EGFR) therapy.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2717352 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2023-11-17 | MODEL2310150001 | BioModels
2021-07-19 | GSE178706 | GEO
| 2332565 | ecrin-mdr-crc
2021-04-07 | GSE149206 | GEO
2023-03-13 | GSE217162 | GEO
2012-04-01 | E-MEXP-3410 | biostudies-arrayexpress
2015-08-01 | E-GEOD-65208 | biostudies-arrayexpress
| 2365524 | ecrin-mdr-crc
2024-08-04 | GSE181436 | GEO
2024-08-04 | GSE181947 | GEO